ADHD Drug CTx-1301 Receives Complete Response Letter - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ADHD Drug CTx-1301 Receives Complete Response Letter

Company says the agency requested additional Chemistry, Manufacturing and Controls information.

  • By

  • Kathryn Wighton

  • June 2, 2026

  • 2 min

Share

Original Source(s)

ADHD Drug CTx-1301 Receives Complete Response Letter

  • by Kathryn Wighton

  • June 2, 2026

Related Content

Augmented reality-based fine arts education experiences and adolescents’ perceived reduction in depressive symptoms: a self-report study of associations with psychological resilience, rumination, and emotional regulation

A meta-analysis of influencing factors of non-suicidal self-injury behavior in adolescents with depression

Altered EEG microstate dynamics in adolescents with non-suicidal self-injury at rest and following acute social exclusion